Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis

Megan Rossi, Kerenaftali Klein, David W Johnson, Katrina L Campbell

Research output: Contribution to journalArticleResearchpeer-review

58 Citations (Scopus)

Abstract

Objective. This paper assessed the effectiveness of pre-, pro-, and synbiotics on reducing two protein-bound uremic toxins, p-cresyl sulphate (PCS) and indoxyl sulphate (IS). Methods. English language studies reporting serum, urinary, or fecal PCS and/or IS (or their precursors) following pre-, pro-, or synbiotic interventions (>1 day) in human adults were included. Population estimates of differences in the outcomes between the pre- and the postintervention were estimated for subgroups of studies using four meta-analyses. Quality was determined using the GRADE approach. Results. 19 studies met the inclusion criteria, 14 in healthy adults and five in haemodialysis patients. Eight studies investigated prebiotics, six probiotics, one synbiotics, one both pre- and probiotics, and three studies trialled all three interventions. The quality of the studies ranged from moderate to very low. 12 studies were included in the meta-analyses with all four meta-analyses reporting statistically significant reductions in IS and PCS with pre- and probiotic therapy. Conclusion. There is a limited but supportive evidence for the effectiveness of pre- and probiotics on reducing PCS and IS in the chronic kidney disease population. Further studies are needed to provide more definitive findings before routine clinical use can be recommended.

Original languageEnglish
Article number673631
Number of pages20
JournalInternational Journal of Nephrology
Volume2012
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Synbiotics
Probiotics
Indican
Meta-Analysis
Prebiotics
Sulfates
Chronic Renal Insufficiency
Population
Renal Dialysis
Language
Serum

Cite this

Rossi, Megan ; Klein, Kerenaftali ; Johnson, David W ; Campbell, Katrina L. / Pre-, pro-, and synbiotics : do they have a role in reducing uremic toxins? A systematic review and meta-analysis. In: International Journal of Nephrology. 2012 ; Vol. 2012.
@article{265d2a8904804b91a8d4f8dbdc5e410a,
title = "Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis",
abstract = "Objective. This paper assessed the effectiveness of pre-, pro-, and synbiotics on reducing two protein-bound uremic toxins, p-cresyl sulphate (PCS) and indoxyl sulphate (IS). Methods. English language studies reporting serum, urinary, or fecal PCS and/or IS (or their precursors) following pre-, pro-, or synbiotic interventions (>1 day) in human adults were included. Population estimates of differences in the outcomes between the pre- and the postintervention were estimated for subgroups of studies using four meta-analyses. Quality was determined using the GRADE approach. Results. 19 studies met the inclusion criteria, 14 in healthy adults and five in haemodialysis patients. Eight studies investigated prebiotics, six probiotics, one synbiotics, one both pre- and probiotics, and three studies trialled all three interventions. The quality of the studies ranged from moderate to very low. 12 studies were included in the meta-analyses with all four meta-analyses reporting statistically significant reductions in IS and PCS with pre- and probiotic therapy. Conclusion. There is a limited but supportive evidence for the effectiveness of pre- and probiotics on reducing PCS and IS in the chronic kidney disease population. Further studies are needed to provide more definitive findings before routine clinical use can be recommended.",
author = "Megan Rossi and Kerenaftali Klein and Johnson, {David W} and Campbell, {Katrina L}",
year = "2012",
doi = "10.1155/2012/673631",
language = "English",
volume = "2012",
journal = "International Journal of Nephrology",
issn = "2090-214X",
publisher = "Hindawi Publishing Corporation",

}

Pre-, pro-, and synbiotics : do they have a role in reducing uremic toxins? A systematic review and meta-analysis. / Rossi, Megan; Klein, Kerenaftali; Johnson, David W; Campbell, Katrina L.

In: International Journal of Nephrology, Vol. 2012, 673631, 2012.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Pre-, pro-, and synbiotics

T2 - do they have a role in reducing uremic toxins? A systematic review and meta-analysis

AU - Rossi, Megan

AU - Klein, Kerenaftali

AU - Johnson, David W

AU - Campbell, Katrina L

PY - 2012

Y1 - 2012

N2 - Objective. This paper assessed the effectiveness of pre-, pro-, and synbiotics on reducing two protein-bound uremic toxins, p-cresyl sulphate (PCS) and indoxyl sulphate (IS). Methods. English language studies reporting serum, urinary, or fecal PCS and/or IS (or their precursors) following pre-, pro-, or synbiotic interventions (>1 day) in human adults were included. Population estimates of differences in the outcomes between the pre- and the postintervention were estimated for subgroups of studies using four meta-analyses. Quality was determined using the GRADE approach. Results. 19 studies met the inclusion criteria, 14 in healthy adults and five in haemodialysis patients. Eight studies investigated prebiotics, six probiotics, one synbiotics, one both pre- and probiotics, and three studies trialled all three interventions. The quality of the studies ranged from moderate to very low. 12 studies were included in the meta-analyses with all four meta-analyses reporting statistically significant reductions in IS and PCS with pre- and probiotic therapy. Conclusion. There is a limited but supportive evidence for the effectiveness of pre- and probiotics on reducing PCS and IS in the chronic kidney disease population. Further studies are needed to provide more definitive findings before routine clinical use can be recommended.

AB - Objective. This paper assessed the effectiveness of pre-, pro-, and synbiotics on reducing two protein-bound uremic toxins, p-cresyl sulphate (PCS) and indoxyl sulphate (IS). Methods. English language studies reporting serum, urinary, or fecal PCS and/or IS (or their precursors) following pre-, pro-, or synbiotic interventions (>1 day) in human adults were included. Population estimates of differences in the outcomes between the pre- and the postintervention were estimated for subgroups of studies using four meta-analyses. Quality was determined using the GRADE approach. Results. 19 studies met the inclusion criteria, 14 in healthy adults and five in haemodialysis patients. Eight studies investigated prebiotics, six probiotics, one synbiotics, one both pre- and probiotics, and three studies trialled all three interventions. The quality of the studies ranged from moderate to very low. 12 studies were included in the meta-analyses with all four meta-analyses reporting statistically significant reductions in IS and PCS with pre- and probiotic therapy. Conclusion. There is a limited but supportive evidence for the effectiveness of pre- and probiotics on reducing PCS and IS in the chronic kidney disease population. Further studies are needed to provide more definitive findings before routine clinical use can be recommended.

U2 - 10.1155/2012/673631

DO - 10.1155/2012/673631

M3 - Article

VL - 2012

JO - International Journal of Nephrology

JF - International Journal of Nephrology

SN - 2090-214X

M1 - 673631

ER -